Showing results (401-410 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|December 14, 2017
Hepatocellular Carcinoma with Macrovascular Invasion: Defining the Optimal Treatment StrategyCharlotte E Costentin, Cristina R Ferrone, Ronald S Arellano, et al.
Liver Cancer|May 12, 2021
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective StudyChanghoon Yoo, Jwa Hoon Kim, Min-Hee Ryu, et al.
Liver Cancer|May 12, 2021
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal VeinYumi Kosaka, Tomoki Kimura, Tomokazu Kawaoka, et al.
Liver Cancer|May 29, 2015
Yttrium-90 microspheres: a review of its emerging clinical indicationsNatthida Khajornjiraphan, Nyein Aye Thu, Pierce Kah Hoe Chow
Liver Cancer|May 29, 2015
Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinomaAbby B Siegel, Anthony B El-Khoueiry, Richard S Finn, et al.
Liver Cancer|May 14, 2020
Microvascular Invasion and a Size Cutoff Value of 2 cm Predict Long-Term Oncological Outcome in Multiple Hepatocellular Carcinoma: Reappraisal of the American Joint Committee on Cancer Staging System and Validation Using the Surveillance, Epidemiology, and End-Results DatabaseJunichi Shindoh, Yuta Kobayashi, Yusuke Kawamura, et al.
Liver Cancer|May 14, 2020
Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive BiomarkerChang Min Kim, Shin Hwang, Bhumsuk Keam, et al.
Liver Cancer|May 14, 2020
Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral TherapyTai-Chung Tseng, Cheng-Yuan Peng, Yao-Chun Hsu, et al.
Liver Cancer|August 20, 2021
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 StudyShukui Qin, Zhenggang Ren, Yin-Hsun Feng, et al.
Liver Cancer|August 20, 2021
Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with AntiviralsTatsuya Minami, Ryosuke Tateishi, Naoto Fujiwara, et al.
Pageof 55